0001939796-22-000003.txt : 20220824 0001939796-22-000003.hdr.sgml : 20220824 20220824123444 ACCESSION NUMBER: 0001939796-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20220824 DATE AS OF CHANGE: 20220824 EFFECTIVENESS DATE: 20220824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RevOpsis Therapeutics, Inc. CENTRAL INDEX KEY: 0001939796 IRS NUMBER: 883217217 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456854 FILM NUMBER: 221190357 BUSINESS ADDRESS: STREET 1: 4109 CHANDLERWOOD CITY: SPRINGFIELD STATE: IL ZIP: 62711 BUSINESS PHONE: 6462215178 MAIL ADDRESS: STREET 1: 4109 CHANDLERWOOD CITY: SPRINGFIELD STATE: IL ZIP: 62711 D 1 primary_doc.xml X0708 D LIVE 0001939796 RevOpsis Therapeutics, Inc. 4109 Chandlerwood Rd. Springfield IL ILLINOIS 62711 6462215178 DELAWARE RevOpsis Therapeutics, Corp RevOpsis Therapeutics, LLC Front Range Ophthalmics, LLC None Corporation true 2022 Ramanath Bhandari 4109 Chandlerwood Rd Springfield IL ILLINOIS 62711 Executive Officer Director Promoter Ram P Palanki 4109 Chandlerwood Rd. Springfield IL ILLINOIS 62711 Executive Officer Director Jeff Olson 4109 Chandlerwood Rd. Springfield IL ILLINOIS 62711 Director Biotechnology Decline to Disclose 06c false 2022-08-19 false true Simple Agreement for Future Equity false 25000 18000000 100000 17900000 false 1 0 0 0 false RevOpsis Therapeutics, Inc. Ramanath Bhandari Ramanath Bhandari President and CEO 2022-08-24